Letter
Standardized Brain Tumor Imaging Protocol for Clinical Trials
G.V. Goldmacher, B.M. Ellingson, J. Boxerman, D. Barboriak, W.B. Pope and M. Gilbert
American Journal of Neuroradiology October 2015, 36 (10) E65-E66; DOI: https://doi.org/10.3174/ajnr.A4544
G.V. Goldmacher
aDepartment of Medical and Scientific Affairs
ICON Clinical Research
Warrington, Pennsylvania
B.M. Ellingson
bDavid Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California
J. Boxerman
cBrown Alpert Medical School
Brown University
Providence, Rhode Island
D. Barboriak
dDepartment of Radiology
Duke University School of Medicine
Durham, North Carolina
W.B. Pope
eDepartment of Radiology
UCLA Medical Center
Los Angeles, California
M. Gilbert
fCenter for Cancer Research
National Institutes of Health
Bethesda, Maryland

REFERENCES
- 1.↵
- Ellingson B,
- Bendszus M,
- Boxerman J, et al
- 2.↵European Organisation for Research and Treatment of Cancer. Bevacizumab and lomustine for recurrent GBM. http://clinicaltrials.gov/show/NCT01290939. Accessed July 30, 2015.
In this issue
American Journal of Neuroradiology
Vol. 36, Issue 10
1 Oct 2015
Advertisement
G.V. Goldmacher, B.M. Ellingson, J. Boxerman, D. Barboriak, W.B. Pope, M. Gilbert
Standardized Brain Tumor Imaging Protocol for Clinical Trials
American Journal of Neuroradiology Oct 2015, 36 (10) E65-E66; DOI: 10.3174/ajnr.A4544
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Similar Articles
Advertisement